Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #901 | January 22, 2021  

SF Logo National Conference Tag

Sign Up for 2021 Conference eAlerts

July 17-28, 2021: Virtual National Conference

The 2021 National Patient Education Conference will take place virtually to protect the health of individuals who have scleroderma and all who participate. The two days of workshops, panels, and speakers are Saturday and Sunday, July 17 and 18. Details regarding registration, workshops and speakers are being finalized. Stay in the know by subscribing to Conference eAlerts.

CONFERENCE eALERTS 

ATS ALA CHEST combined logo

During Pandemic, Critical to Work with Doctor to Manage Lung Disease Symptoms

Three national lung health organizations highlight the need for individuals with chronic lung disease to continue working closely with their health care provider to manage their health through medications, preventative care, and recommended screenings. 

American Thoracic Society, American Lung Association, and American College of Chest Physicians issued a press release together on January 12 and stated "Our organizations urge patients to work closely with their health care provider to manage their symptoms and get tested for COVID-19 as recommended by their doctors and the Centers for Disease Control and Prevention (CDC)."

READ

MSAB COVID-19 eLetter Graphic

COVID‑19 Information & Recommendations

Updated January 8, 2021

Information and frequently asked questions regarding the COVID-19 vaccines have been addressed by the Scleroderma Foundation's Medical & Scientific Advisory Board, to be used in consultation with your rheumatologist or other health care provider.

These guidelines, along with more information and recommendations for individuals affected by scleroderma about COVID-19 are posted at scleroderma.org/covid19. Please check this page from time to time for updates.

COVID‑19

Children's Friend Seven Hills Foundation

Caregivers of Children, Mental Health Access

Two outpatient therapists at Children's Friend are studying caregivers' experiences in accessing mental health treatment for their children. Caregivers include biological parents, adoptive parents, foster parents, stepparents, and/or guardians of children under the age of 18 living anywhere in the United States. Please consider completing their anonymous online survey (10-20 minutes) to provide valuable feedback to assist mental health providers in tailoring services to better meet the needs of families.

English: https://www.surveymonkey.com/r/PQFSMVV
Español: https://es.surveymonkey.com/r/2DXD5TX

Please direct questions to Kim Hager, L.I.C.S.W., khager@childrensfriend.org or Maria Martinez Calderon, L.M.H.C., mmartinez@childrensfriend.org.

Michigan Webinar January 2021

Scleroderma Caregivers & Mental Health

VIDEO

Are you a caregiver for a loved one with scleroderma? We know the emotional challenges you may face, and we’re here to help. Watch our January webinar to learn about support services and resources to help you succeed.

Featuring Danielle Rice, a therapist and a PhD candidate at the Department of Psychology at McGill University, Montreal, Quebec.

WATCH

Ticket to Work WISE ChooseWork

Services & Supports

WEBINAR: January 27, 2021; 3 p.m. Eastern

How can a Ticket to Work service provider help you reach your work goals? Find out during this month’s Work Incentive Seminar Event (WISE) webinar. ChooseWork will talk about the free services and supports available to eligible people with disabilities. Connect with a service provider who can help you on the path to financial independence through work.

WEBINAR

Advertisement
Mitsubishi Tenabe Decode Ad 2020
 
Advertisement
Kadmon Trial 2020 kadmonscleroderma.com
 
 
 
QUICK LINKS
 
Advocacy
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Store
Make a Gift
Home
 
SOCIAL MEDIA
 
Facebook
Twitter
Instagram
YouTube
 linkedin-icon
 
SPONSORS
 
Diamond National Sponsors

Actelion Plain

Boehringer Ingelheim Plain

 

Corporate Sponsors

Corbus Pharmaceuticals Logo

Horizon Therapeutics logo

 

 

 

Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2024 All rights reserved.